Lancet:
Long COVID in the general population: reassurance without dismissal
Lemogne, Oct 26
S4ME:
Long COVID in the general population: reassurance without dismissal
- Cedric Lemogne's comment in The Lancet, Regional Health, Europe, upon:
S4ME:
Recovery trajectories and predictors of symptom resolution in post-COVID-19 condition: a population-based cohort study, 2026, Brunet et al.
Cedric Lemogne says: "Two priorities follow:
"First, epidemiological surveillance and outcome assessment should move beyond the presence of any persistent symptom to identify clinically consequential PCC."
[ [ [ What does this mean? Does it broaden the catchment? Does it confuse research"? ] ] ]
[ [ [ Which bits do and don't make sense? ] ] ]
[ [ [ Does it also mean he cannot abide any "syndrome" interfering with his re-defined collections of indecipherable, personalised, somatic "symptoms"? ] ] ]
"This requires pre-infection baselines, repeated measurements, appropriate comparison groups, and
multidimensional assessment of recovery, including symptoms, functioning, and participation.
[9]"
[ [ [ Given the proviso - gone beyond particular symptoms - what comparisons are "appropriate", as proposed? And appropriate to what or who? ] ] ]
[ [ [ Objective and / or subjective measurements? "Recovery" by which scale? Did he already say there is limited recovery in his "polysymptomatic" grouping? ] ] ]
[9] refers to:
A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study
Lancet Respir Med. 2022;
10:715-724
Full Text,
Full Text (PDF),
Scopus (109),
PubMed,
Google Scholar
"Second, treatment research should focus particularly on people who remain polysymptomatic and disabled after the period of fastest improvement."
[ [ [ WOW wow wow
He has accepted the evidence that an initial period of potential improvement did not need "intervention" to modify mind, thought, belief, behaviour and plans - never needed. Misled clinics across England thought it crucial, built a base, contracts, evidence, special interest group and credibility on this pretext, refuse to comply, give no other choice, will not make CBT and loading programs optional. ] ] ]
[ [ [ Eeeeeeeeek, ah, so, he wishes to focus on us - other - survivors instead ] ] ]
[ [ [[ [ [ Polysymptomatic and not recovered - are we talking about ME/CFS/LC? ] ] ]
"Evidence is already emerging:
"cognitive behavioural interventions and combined physical and mental-health rehabilitation
probably improve selected outcomes, although the optimal intervention, target phenotype, and timing
remain uncertain. [10]"
[ [ [ Yet another big fat research budget? Please. Don't give it to them instead, give it back to us. As
@neophyte32 identified -
a spectacular role reversal. ] ] ]
[ [ [ Ok, so. Is his evidence high or low quality for his
"probability"? Did France really want to swerve off-road upon his probability? ] ] ]
[ [ [ "Target phenotype" Said Wallitt and Wessely.
Uncertain target - hold your fire. We can all bank on
uncertainty. Social security and social service can maintain indefinitely all the suspicion it planned to resolve. More unresolved suspicion is more power to your elbow, when push comes to shove. Not at all sociable. ] ] ]
[10] refers to:
Interventions for the management of long covid (post-covid condition): living systematic review,
Zeraatkar, D. ∙ Ling, M. ∙ Kirsh, S. ∙ et al.
BMJ. 2024;
387, e081318
Crossref,
Scopus (41),
PubMed,
Google Scholar
"The next challenge is therefore not simply to count long COVID, but to identify early who will recover, who will not, and what can alter these trajectories."
[ [ [ Mind control? ] ] ]
Contributors
- Cédric Lemogne:
- writing—original draft.
Declaration of interests
- Cédric Lemogne's work on post-COVID-19 condition in the past 36 months has been supported by:
ANRS|MIE (Agence nationale de recherche sur le Sida et les hépatites virales | Maladies infectieuses émergentes).
